From: Genomic alterations in normal breast tissues preceding breast cancer diagnosis
 | Healthy controls (n = 81) | Pre-diagnosis tissues (n = 79) | P value |
---|---|---|---|
Age, mean (range) | 53.9 (29–73) | 53.6 (28–74) | 0.837a |
BMI, mean (SD) | 30.4 (6.3) | 30.6 (6.5) | 0.904a |
Tyrer-Cuzick lifetime risk score, mean (SD) | 12.7 (6.7) | 13.4 (9.7) | 0.594a |
Self-reported ethnicity, n (%) | |||
Black | 17 (21.0%) | 17 (21.5%) | 1b |
White | 62 (76.5%) | 60 (75.9%) | Â |
Others | 2 (2.5%) | 2 (2.6%) | Â |
Menopausal status, n (%) | |||
Pre-menopausal | 23 (28.4%) | 23 (28.8%) | 0.476b |
Post-menopausal | 53 (65.4%) | 47 (60.0%) | Â |
Others | 5 (6.2%) | 9 (11.2%) | Â |
Has blood relatives with cancer, n (%) | |||
Yes | 43 (53.1%) | 44 (55.0%) | 1b |
No | 34 (42.0%) | 33 (42.5%) | Â |
 | NA (4.9%) | NA (2.5%) |  |
Time to diagnosis in years, mean (range) | NA | 4.7 (0–11) |  |
Follow-up time from donation year, mean (range) | 6.1 (0–14) | NA |  |